| | | | | | | | | | | | | | | | | | | | | |
<?xml version="1.0" encoding="windows-1252"?> |
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink"> |
| <link:schemaRef xlink:href="rmd-20220613.xsd" xlink:type="simple"/> |
| <context id="duration_2022-06-13_to_2022-06-13"> |
| | <entity> |
| | | <identifier scheme="http://www.sec.gov/CIK"> 0000943819 </identifier> |
| | | </entity> |
| | <period> |
| | | <startDate> 2022-06-13 </startDate> |
| | | <endDate> 2022-06-13 </endDate> |
| | | </period> |
| | </context> |
| <dei:EntityRegistrantName contextRef="duration_2022-06-13_to_2022-06-13" id="Hidden_dei_EntityRegistrantName"> RESMED INC </dei:EntityRegistrantName> |
| <dei:EntityAddressCountry contextRef="duration_2022-06-13_to_2022-06-13" id="Hidden_dei_EntityAddressCountry_duration_2022-06-13_to_2022-06-13"> US </dei:EntityAddressCountry> |
| <dei:AmendmentFlag contextRef="duration_2022-06-13_to_2022-06-13"> true </dei:AmendmentFlag> |
| <dei:EntityCentralIndexKey contextRef="duration_2022-06-13_to_2022-06-13" id="Hidden_dei_EntityCentralIndexKey"> 0000943819 </dei:EntityCentralIndexKey> |
| <dei:DocumentType contextRef="duration_2022-06-13_to_2022-06-13"> 8-K/A </dei:DocumentType> |
| <dei:DocumentPeriodEndDate contextRef="duration_2022-06-13_to_2022-06-13"> 2022-06-13 </dei:DocumentPeriodEndDate> |
| <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-06-13_to_2022-06-13"> DE </dei:EntityIncorporationStateCountryCode> |
| <dei:EntityFileNumber contextRef="duration_2022-06-13_to_2022-06-13"> 001-15317 </dei:EntityFileNumber> |
| <dei:EntityTaxIdentificationNumber contextRef="duration_2022-06-13_to_2022-06-13"> 98-0152841 </dei:EntityTaxIdentificationNumber> |
| <dei:EntityAddressAddressLine1 contextRef="duration_2022-06-13_to_2022-06-13"> 9001 Spectrum Center Blvd. </dei:EntityAddressAddressLine1> |
| <dei:EntityAddressCityOrTown contextRef="duration_2022-06-13_to_2022-06-13"> San Diego </dei:EntityAddressCityOrTown> |
| <dei:EntityAddressStateOrProvince contextRef="duration_2022-06-13_to_2022-06-13"> CA </dei:EntityAddressStateOrProvince> |
| <dei:EntityAddressPostalZipCode contextRef="duration_2022-06-13_to_2022-06-13"> 92123 </dei:EntityAddressPostalZipCode> |
| <dei:CityAreaCode contextRef="duration_2022-06-13_to_2022-06-13"> (858) </dei:CityAreaCode> |
| <dei:LocalPhoneNumber contextRef="duration_2022-06-13_to_2022-06-13"> 836-5000 </dei:LocalPhoneNumber> |
| <dei:WrittenCommunications contextRef="duration_2022-06-13_to_2022-06-13"> false </dei:WrittenCommunications> |
| <dei:SolicitingMaterial contextRef="duration_2022-06-13_to_2022-06-13"> false </dei:SolicitingMaterial> |
| <dei:PreCommencementTenderOffer contextRef="duration_2022-06-13_to_2022-06-13"> false </dei:PreCommencementTenderOffer> |
| <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-06-13_to_2022-06-13"> false </dei:PreCommencementIssuerTenderOffer> |
| <dei:Security12bTitle contextRef="duration_2022-06-13_to_2022-06-13"> Common Stock, $0.004 par value </dei:Security12bTitle> |
| <dei:TradingSymbol contextRef="duration_2022-06-13_to_2022-06-13"> RMD </dei:TradingSymbol> |
| <dei:SecurityExchangeName contextRef="duration_2022-06-13_to_2022-06-13"> NYSE </dei:SecurityExchangeName> |
| <dei:EntityEmergingGrowthCompany contextRef="duration_2022-06-13_to_2022-06-13"> false </dei:EntityEmergingGrowthCompany> |
| <dei:AmendmentDescription contextRef="duration_2022-06-13_to_2022-06-13"> This amendment on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K filed by ResMed Inc. (“ResMed”) on June 14, 2022 (the “Original Report”) disclosing that on June 13, 2022 ResMed entered into a Sale and Purchase Agreement (the “Purchase Agreement”) with Mondstein 483. GmbH, a limited liability company under the laws of Germany and wholly-owned indirect subsidiary of ResMed and Miami Holding S.ŕ r.l., a limited liability company under the laws of the Grand Duchy of Luxembourg. This Amendment amends and restates the Original Report in its entirety by making the disclosure of the entering into the Purchase Agreement and related description of such Purchase Agreement an Item 8.01 Other Events disclosure rather than an Item 1.01 Entry into a Material Definitive Agreement disclosure as provided by the general instructions for the use of the Current Report on Form 8-K. The Original Report and this Amendment continue to speak as of the date of the Original Report, and the Company has not updated the disclosures contained herein or therein to reflect any events which occurred at a date subsequent to the filing of the Original Report. </dei:AmendmentDescription> |
| </xbrl> |